<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33231106</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-8298</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>17</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Future cardiology</Title>
          <ISOAbbreviation>Future Cardiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Edoxaban (LIXIANA<sup>®</sup>) in the treatment of venous thromboembolism.</ArticleTitle>
        <Pagination>
          <StartPage>779</StartPage>
          <EndPage>791</EndPage>
          <MedlinePgn>779-791</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2217/fca-2020-0139</ELocationID>
        <Abstract>
          <AbstractText>Standard therapy for venous thromboembolism (VTE) includes the use of heparins and vitamin K antagonists. Randomized clinical trials have shown that non-vitamin K oral anticoagulants are as effective and safe as standard therapy in VTE treatment, with an improved pharmacological profile. Edoxaban, a direct inhibitor of factor Xa, has demonstrated noninferiority to standard therapy for the treatment of VTE, preserving a high safety profile even in long-term therapy, in frail patients and in severe clinical presentations. The present paper focuses on the role of edoxaban in VTE treatment, from general population to cancer patients, presenting the available data from randomized clinical trials and real world, to discuss edoxaban use in clinical practice.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bottino</LastName>
            <ForeName>Roberta</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-2938-4728</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medical Sciences, Division of Cardiology, University of Campania Luigi Vanvitelli, Caserta, 80100, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carbone</LastName>
            <ForeName>Andreina</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-2190-7010</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medical Sciences, Division of Cardiology, University of Campania Luigi Vanvitelli, Caserta, 80100, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liccardo</LastName>
            <ForeName>Biagio</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Monaldi Hospital, Naples, 80131, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>D'Andrea</LastName>
            <ForeName>Antonello</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-9698-9145</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Umberto I Hospital, Nocera Inferiore, 84014, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rago</LastName>
            <ForeName>Anna</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-9252-2997</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medical Sciences, Division of Cardiology, University of Campania Luigi Vanvitelli, Caserta, 80100, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Papa</LastName>
            <ForeName>Andrea Antonio</ForeName>
            <Initials>AA</Initials>
            <Identifier Source="ORCID">0000-0002-5654-4686</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medical Sciences, Division of Cardiology, University of Campania Luigi Vanvitelli, Caserta, 80100, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spaccarotella</LastName>
            <ForeName>Carmen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical &amp; Surgical Sciences, Division of Cardiology, University Magna Graecia, Catanzaro, 88100, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Golino</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0002-3590-6983</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medical Sciences, Division of Cardiology, University of Campania Luigi Vanvitelli, Caserta, 80100, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nigro</LastName>
            <ForeName>Gerardo</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0003-1776-8449</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medical Sciences, Division of Cardiology, University of Campania Luigi Vanvitelli, Caserta, 80100, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Russo</LastName>
            <ForeName>Vincenzo</ForeName>
            <Initials>V</Initials>
            <Identifier Source="ORCID">0000-0002-9227-0360</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medical Sciences, Division of Cardiology, University of Campania Luigi Vanvitelli, Caserta, 80100, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Future Cardiol</MedlineTA>
        <NlmUniqueID>101239345</NlmUniqueID>
        <ISSNLinking>1479-6678</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D065427">Factor Xa Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013844">Thiazoles</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>NDU3J18APO</RegistryNumber>
          <NameOfSubstance UI="C552171">edoxaban</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D065427" MajorTopicYN="N">Factor Xa Inhibitors</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013844" MajorTopicYN="N">Thiazoles</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">cancer</Keyword>
        <Keyword MajorTopicYN="Y">deep venous thrombosis</Keyword>
        <Keyword MajorTopicYN="Y">direct oral anticoagulant</Keyword>
        <Keyword MajorTopicYN="Y">edoxaban</Keyword>
        <Keyword MajorTopicYN="Y">oral anticoagulation</Keyword>
        <Keyword MajorTopicYN="Y">pulmonary embolism</Keyword>
        <Keyword MajorTopicYN="Y">venous thromboembolism</Keyword>
        <Keyword MajorTopicYN="Y">vitamin K antagonist</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>24</Day>
          <Hour>8</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33231106</ArticleId>
        <ArticleId IdType="doi">10.2217/fca-2020-0139</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
